IntroductIon
Fatigue is a debilitating symptom that affects all age groups and can impact on patients' quality of life. It is now recognised that the symptom of fatigue can occur in association with a wide range of chronic diseases, can be unexplained (chronic fatigue or idiopathic fatigue) or can occur in conjunction with a constellation of symptoms that form the chronic fatigue syndrome (CFS). A recent study found that 25% of all general practitioner (GP) consultations were characterised by the symptom of fatigue; in 6.5% of consultations fatigue was the main reason for GP attendance. 1 In 2006, the UK's National Institute for Health and Clinical Excellence (NICE) produced guidelines recommending that patients who fulfil the diagnostic criteria for CFS be referred to a specialist CFS clinical service. 2 The Department of Health (DOH) consequently funded clinical services aimed at diagnosing and managing the symptoms of CFS. However, these services are not available to those who do not fulfil the diagnostic criteria for CFS.
Chronic fatigue syndrome is a clinical condition characterised by disabling fatigue in conjunction with a constellation of symptoms, including musculoskeletal pain, poor memory and concentration and sleep disturbance. [3] [4] [5] It affects all age groups and is associated with significant functional impairment. 6 Currently, there is no diagnostic test for CFS, making it frequently a diagnosis of exclusion, which is dependent on ensuring fatigued patients do not have another fatigue-associated diagnosis. Although the NICE guidelines prompt the exclusion of a number of such conditions, as medical knowledge and recognition of fatigue in association with chronic diseases improves there is the concern that without increased education, referrers to CFS services will not recognise the 'newer' fatigue-associated diseases and that the proportion of those referred to the DOHfunded CFS services who do not fulfil the diagnostic criteria for CFS will increase. 
Methodology
All referrals made to the Newcastle CFS Clinical Service are entered into a database. The CFS database was interrogated to include every patient referred to the service from November 2008 to December 2009. All patients who did not attend their appointments (resulting in no diagnosis being made by our service) were excluded. After these exclusions, 260 patients were seen by the service during the 14-month period. All medical notes for each patient were reviewed and the diagnosis, sex and age recorded. Results were compared with a previous small service audit performed in 2007. In this previous, limited audit, all referrals made to the service between January 2005 and December 2007 were reviewed. A random sample of 56 patients' notes was reviewed from the 375 patients seen during that period.
The UK national minimum dataset uses the Fukuda diagnostic criteria for CFS. 7 Those whose symptoms matched the criteria were considered to have CFS. Within the CFS group we considered three particular clinical phenotypes:
Positional orthostatic tachycardia syndrome (POTS).
• This is a recently recognised association with CFS. 8, 9 Its diagnosis is made when patients experience symptoms on standing in association with a rise in heart rate to above 120 beats per minute (bpm) or by 30 bpm; CFS/fibromyalgia overlap; • Those who described their symptoms as being • precipitated by a viral or bacterial infection.
Where subjects did not fulfil the Fukuda criteria for CFS, their diagnoses were classified into: 
Analysis
All data were normally distributed. Comparisons were therefore made between the proportions in each group using Fisher's exact test (F) and between continuous variables using the Student's unpaired t-test (T). Results were considered to be significant at the p=0.05 level.
Approvals
Review by the local research and development department considered that this was a service evaluation. Data storage was approved by the Caldicott guardian and the data protection officer. In the 2008-09 cohort, there were no significant age differences between those found to have CFS and those found to have other fatigue-associated diseases (non-CFS 41 years ± 13 vs CFS 41 years ± 14; T p=1.0) and the proportion of males was significantly lower in the group ultimately diagnosed with CFS (non-CFS 34/103 [33%] vs 33/157 [21%]; F p=0.05).
In the CFS group, four patients were found to have a CFS/POTS phenotype (3%), 31 had CFS precipitated by an infective episode (20%) and four had a CFS/ fibromyalgia phenotype (3%).
Forty per cent of patients seen by our service were subsequently found not to have CFS. Their relative proportions and specific diagnostic groups are shown in Figure 1 and Table 1 . The most common diagnosis in these patients was fatigue associated with a chronic disease, 47% of all alternative diagnoses. This was followed by primary sleep disorders (20%), which included eight patients with obstructive sleep apnoea (OSA), 12 with another primary sleep disorder, one patient with restless leg syndrome (RLS) and one patient with both RLS and OSA. Fifteen per cent of all alternative diagnoses were psychological/psychiatric illnesses, and 4% were cardiovascular disorders. In 13% of these patients the cause for fatigue remained unexplained (5.2% of total referrals).
The conditions most commonly seen in the group that had a psychological illness contributing to their fatigue were depression, anxiety and post-traumatic stress disorder. The cardiovascular diagnoses were vasovagal syncope in patients with fatigue symptoms who also had a history of episodes of loss of consciousness. The diagnosis was made after a reproduction of symptoms in head-up tilt testing.
dIScuSSIon
This study has shown a significant increase over the past four years in the proportion of patients referred by GPs to an NHS CFS service who were subsequently diagnosed with CFS. This may be due to an improved recognition of CFS by GPs or hospital doctors due to better training or increased awareness of the guidelines. Alternatively it may be related to an increased awareness of fatigue-associated chronic diseases, which could lead to increased recognition and diagnosis by GPs and hospital doctors and referrals to specialty-specific clinics rather than a CFS clinic.
It is a matter for debate whether this pathway of care for the management of fatigue in those who have a chronic disease is appropriate. The focus of management in the majority of chronic disease clinics is often on monitoring the progression of the underlying disease. However, studies exploring the aetiology of fatigue in a number of chronic diseases have shown that the fatigue experienced by patients is unrelated to the underlying disease severity, [10] [11] [12] [13] with the implication that improving chronic disease management may not lead to improvements in the symptoms experienced by patients.
It is becoming evident that fatigue is a generic symptom that affects large numbers of patients and that perceived fatigue is comparable across different diseases; management strategies that work for fatigue in one disease may therefore also be appropriate in others. 14 However, in the NHS in England and Wales only patients with fatigue who fulfil the Fukuda criteria for CFS can currently access specialist fatigue management services.
Our work suggests that large numbers of patients with fatigue are unable to access these specialist services and we believe that the current NHS has nothing to offer in the way of evidence-based management for this patient group. We would suggest that, like pain (where pain clinics have developed over the past decade), fatigue is a generic symptom, the management of which is not always appropriately met by the disease-specific chronic disease clinics typical of current NHS practice.
In Europe, the model of care is centred on the symptom of fatigue rather than the underlying disease process, with established fatigue management clinics effectively managing this symptom. As in Europe, we believe that fatigue is an important symptom, leading to functional impairment and significantly affecting patients' quality of life, and that developing an appropriate evidence base to optimise its management is vital if improvements in chronic disease management are to be realised.
Our patients with alternative diagnoses to CFS showed some interesting trends. The largest proportion had fatigue related to chronic diseases, most commonly connective tissue diseases, diabetes mellitus, nonalcoholic fatty liver disease and chronic lung diseases. This finding emphasises how important it is to be aware that these diseases are increasingly being recognised as associated with fatigue and that considering this in a holistic assessment of patients will optimise outcomes.
Moreover, one fifth of our patients with alternative fatigue-associated diseases were diagnosed with sleep disorders -an important, potentially treatable diagnostic group. Fatigue services therefore need to ensure effective links with sleep clinics.
In conclusion, we suggest that referral networks are established for fatigue evaluation and management, specifically for departments that commonly manage chronic diseases.
Disease Number
Metabolic syndrome 8
Neurological disorder 13
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